cro.directory
← Compare landing

Innovate Research vs Krescent Medical Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/innovate-research/krescentmr

CategoryInnovate ResearchKrescent Medical Research
Listed sitecrocro
SummaryIndian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.Full-service preclinical and clinical CRO supporting pharmaceutical, biotechnology, and medical device companies with trial design, site selection, data management, statistical analysis, and medical writing across Asia-Pacific.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
Modalities
  • Small Molecule
  • Biologics (Other)
  • Vaccine
Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Noida, Uttar Pradesh, India
  • Chapel Hill, Chapel Hill, North Carolina, USA
  • Dubai, Dubai, United Arab Emirates
  • Budapest, Budapest, Hungary
  • Weybridge, Weybridge, Surrey, United Kingdom
  • Headquarters, Pune, Maharashtra, India
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.